Stromal vascular fraction-enriched fat grafting as treatment of adherent scars: study design of a non-randomized early phase trial.
Vriend L., van Dongen JA., Pijpe A., Nieuwenhuis MK., Jongen SJM., Harmsen MC.
Clinical Trial with a reported sample of 46 on Burns, Scar, published in Trials (2022) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Trials (2022)
- Country
- England
- Reported sample size
- 46
- Source database
- PubMed
- PMID
- 35854356
- PMCID
- PMC9295521
- DOI
- 10.1186/s13063-022-06514-3
- Citations
- 3
Abstract (original English)
Background In the last decades, autologous fat grafting has been used to treat adherent dermal scars. The observed regenerative and scar-reducing properties have been mainly ascribed to the tissue-derived stromal vascular fraction (tSVF) in adipose tissue. Adipose tissue's components augment local angiogenesis and mitosis in resident tissue cells. Moreover, it promotes collagen remodeling. We hypothesize that tSVF potentiates fat grafting-based treatment of adherent scars. Therefore, this study aims to investigate the effect of tSVF-enriched fat grafting on scar pliability over a 12-month period. Methods and design A clinical multicenter non-randomized early phase trial will be conducted in two dedicated Dutch Burn Centers (Red Cross Hospital, Beverwijk, and Martini Hospital, Groningen). After informed consent, 46 patients (≥18 years) with adherent scars caused by burns, necrotic fasciitis, or degloving injury who have an indication for fat grafting will receive a sub-cicatricic tSVF-enriched fat graft. The primary outcome is the change in scar pliability measured by the Cutometer between pre- and 12 months post-grafting. Secondary outcomes are scar pliability (after 3 months), scar erythema, and melanin measured by the DSM II Colormeter; scar quality assessed by the patient and observer scales of the Patient and Observer Scar Assessment Scale (POSAS) 2.0; and histological anal
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review
Systematic Review with a reported sample of 420 on Burns, Scar, published in Lasers Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 420
Lasers Med Sci - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Plant-Derived Nanovesicles as Cell-Free Therapies for Thermal Burn Healing: A Systematic Review of Preclinical Evidence and Delivery Strategies
Systematic Review on Chronic Wound, Burns, Scar, Chronic Inflammation, published in Med Sci (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Med Sci (Basel) - Level ASystematic ReviewPubMed
Autologous Nanofat Indications in Wound Healing: A Systematic Review.
Systematic Review with a reported sample of 3 on Chronic Wound, Burns, Scar, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3
Biomedicines - Level AMeta-analysisEurope PMC
Systematic review and meta-analysis of the use of micrografting technology in humans
Meta-analysis with a reported sample of 24 on Chronic Wound, Burns, Hair Loss, published in J Int Med Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 24
J Int Med Res1 citations - Level ASystematic ReviewPubMed
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel: Regenerative Therapy for Burn Wound Healing.
Systematic Review on Chronic Wound, Burns, Scar, published in Ann Plast Surg (2025) — summary generated from the PubMed abstract.
- 2025
Ann Plast Surg - Level AMeta-analysisEurope PMC
Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Chronic Wound, Burns, Scar, Chronic Inflammation, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med11 citations